Literature Network » Anonymous

Anonymous Patient Centric Data From PharMetrics, Which Identifies Market Growth Opportunities, Suggest Pharmaceutical Companies Are Leaving $27 Billion 'On the Table' in Statin Category.

Content courtesy of

From: Business Wire
Date: 20030609
Author:

Business Editors/Health/Medical Writers

WATERTOWN, Mass.--(BUSINESS WIRE)--June 9, 2003

"The old way of marketing is no longer good enough to sustain market-leading rates of growth. New approaches that move beyond physician-prescribing data and promotion share-of-voice battles are needed. A complete understanding of the patient treatment landscape, made possible by anonymous patient centric data, is needed to make better decisions."

Gerald J. Gallivan, SVP/Sales (ret.), Merck & Co.'s U.S. Human Health Division; Director, PharMetrics

Data presented at "Anonymous ...

Read the rest of this article with a Free Trial at HighBeam Research.

Other Articles on Anonymous

About Our Articles: We've partnered with Highbeam Research to provide these article excerpts for your research needs. However, due to copyright laws, we cannot publish the whole article. To view these articles in full length you'll need to use the link above to access the free trial at Highbeam.